AKTX Financials

Akari Therapeutics Plc - Financial statements & key metrics

Stock Price

$0.16

Market Cap

$16.96M

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-19.79M

EPS (Diluted)

$0.00

Balance Sheet Highlights

Total Assets

$50.56M

Total Liabilities

$28.33M

Shareholders Equity

Cash & Equivalents

$2.60M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-12.55M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-1.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is AKTX revenue?

View AKTX's income statement for detailed revenue data.

Is AKTX profitable?

AKTX reported a loss of $19.79M in the most recent quarter.

What is AKTX market cap?

AKTX has a market capitalization of $16.96M, making it a small-cap stock.

Does AKTX have debt?

View AKTX's balance sheet for debt information.

What is AKTX cash flow?

Cash flow data is available in the full financial statements.